Market Research Report
The Global Genetic Testing Market by Hereditary, Newborn, NIPT, Oncology, Pharmacogenomic and Direct to Consumer. With Executive and Consultant Guides 2020 to 2024
|Published by||Howe Sound Research||Product code||384217|
|Published||Content info||391 Pages
Delivery time: 1-2 business days
|The Global Genetic Testing Market by Hereditary, Newborn, NIPT, Oncology, Pharmacogenomic and Direct to Consumer. With Executive and Consultant Guides 2020 to 2024|
|Published: November 1, 2019||Content info: 391 Pages||
Will all newborns receive Whole Genomic Sequencing at birth? What key interest is driving Direct to Consumer?
Our facts and support = Your success.
The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth. New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry. The traditional genetic testing market is growing in volume and growing in the breadth of tests creating new life for the industry. The report forecasts the market size out to 2024. The report includes detailed breakouts for 14 countries and 5 regions.
Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.
All report data is available in Excel format on request.
Make investment decisions and valuations with confidence using the latest data.
Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes: